PHARMACOKINETIC INTERACTION BETWEEN IVACAFTOR AND LUMACAFTOR IN CYSTIC FIBROSIS PATIENTS

被引：0
|
作者：
Hanafin, P. [2 ]
Rao, G. [2 ]
Schneider-Futschik, E. [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] UNC Eshelman Sch Pharm, Chapel Hill, NC USA
来源：
RESPIROLOGY | 2020年 / 25卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 070
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [11] Metabolomic responses to lumacaftor/ivacaftor in cystic fibrosis
    Kopp, Benjamin T.
    McCulloch, Scott
    Shrestha, Chandra L.
    Zhang, Shuzhong
    Sarzynski, Lisa
    Woodley, Frederick W.
    Hayes, Don, Jr.
    PEDIATRIC PULMONOLOGY, 2018, 53 (05) : 583 - 591
  • [12] Combination lumacaftor and ivacaftor therapy for cystic fibrosis
    McColley, Susanna A.
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (02): : 233 - 242
  • [13] Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
    Naehrig, Susanne
    Mertsch, Pontus
    Griese, Matthias
    Kappler, Matthias
    Huber, Rudolf M.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [14] Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
    Neerincx, Anne H.
    Whiteson, Katrine
    Phan, Joann L.
    Brinkman, Paul
    Abdel-Aziz, Mahmoud, I
    Weersink, Els J. M.
    Altenburg, Josje
    Majoor, Christof J.
    Maitland-van der Zee, Anke H.
    Bos, Lieuwe D. J.
    ERJ OPEN RESEARCH, 2021, 7 (02)
  • [15] Lumacaftor/ivacaftor: An Observational Study Of Outcomes And Tolerances In Patients With Cystic Fibrosis
    Jennings, M. T.
    Dezube, R.
    Hong, G.
    West, N. E.
    Braun, A.
    Merlo, C.
    Lechtzin, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [16] Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
    Neerincx, Anne H.
    Whiteson, Katrine
    Phan, Joann L.
    Brinkman, Paul
    Abdel-Aziz, Mahmoud, I
    Weersink, Els J. M.
    Altenburg, Josje
    Majoor, Christof J.
    Maitland-Van der Zee, Anke-H
    Bos, Lieuwe D. J.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [17] Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France
    Olivereau, Lucie
    Nave, Viviane
    Garcia, Stephan
    Perceval, Marie
    Rabilloud, Muriel
    Durieu, Isabelle
    Reynaud, Quitterie
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 402 - 406
  • [18] Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
    Schneider, E. K.
    Reyes-Ortega, F.
    Li, J.
    Velkov, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (01) : 130 - 141
  • [19] Is There a Role for Lumacaftor/Ivacaftor in Young Children with Cystic Fibrosis?
    Martin, Isaac
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2025, 22 (03) : 468 - 469
  • [20] Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis
    Shanthikumar, Shivanthan
    Ranganathan, Sarath
    Neeland, Melanie R.
    PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2549 - 2552
12345